本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

泰和誠醫療

4.44
-0.0600-1.33%
成交量:7,494.00
成交額:3.29萬
市值:1,927.72萬
市盈率:-0.37
高:4.62
開:4.59
低:4.16
收:4.50
資料載入中...
2024/04/19

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/17

SEC問詢函

Form CORRESP - Correspondence
2023/07/14

SEC問詢函

Form CORRESP - Correspondence
2023/04/19

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/26

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/19

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/01/16

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2018/12/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/08/30

非美公司披露報告

2018/04/04

非美公司披露報告

2017/12/21

非美公司披露報告